Inflammatory Myopathies Press Releases

Patients with a painful and debilitating muscle disease called dermatomyositis showed dramatic improvement on a treatment
regimen of intravenous immune globulin (IVIG) during a recent double-blind, placebo-controlled trial. The study, which was
conducted at the National Institute of Neurological Disorders and Stroke (NINDS), will be published in the December 30 issue
of the New England Journal of Medicine. Fact Sheet